In addition, to clarify whether our forecast models were superior in forecasting the survival of ESCC patients, compared with previously published biomarkers, we also performed ROC analysis of other known biomarkers, including ZNF750, TTL, AC016205.1, and BOLA3 [12, 13]. Here, BOLA3 is linked to esophageal squamous cell carcinoma.